Myeloma Center


June 17, 2022

Myeloma Patient Celebrates Full Remission by Walking Daughter Down the Aisle

Linda Haymes

“I was very pleased to be able to offer Dave this novel immunotherapy, which takes the patient’s own immune cells and genetically re-programs the cells to attack the myeloma,” Puente's doctor Frits van Rhee said. “I am very excited that Dave tolerated the treatment well and that he has had an excellent response to it.”

Dave Puente of Elk Grove California, the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) last November, recently saw a very personal goal he’d set for himself become a reality. Late last year, during an interview for an article…


March 16, 2022

Study Puts More Than 50 UAMS Faculty Among Top 2% of Influential Researchers

David Robinson

Shuk Mei Ho, Ph.D., UAMS vice chancellor for Research and Innovation, said the lengthy list of influential UAMS faculty is a testament to the institution’s high priority for research.

LITTLE ROCK — A study by Stanford University lists over 50 current and retired UAMS faculty among the top 2% of most influential researchers. The study is based on an analysis of Scopus, the largest database of peer-reviewed research literature. To determine the most influential researchers, the study authors used a combination of citation metrics…


February 28, 2022

Danyelle Musselman to Emcee UAMS Winthrop P. Rockefeller Cancer Institute’s ‘Be a Part of the Cure’ Walk on April 30

Marty Trieschmann

Be A Part of the Cure Walk Logo

On April 30, the first lady of Arkansas Razorback Men’s Basketball, Danyelle Musselman, will emcee the UAMS Winthrop P. Rockefeller Cancer Institute’s “Be a Part of the Cure” Walk honoring all Arkansas cancer patients.


January 20, 2022

Winthrop P. Rockefeller Cancer Institute’s Radiation Oncology Center Becomes First and Only Center in Arkansas to Earn APEx Accreditation

Marty Trieschmann

UAMS Radiation Oncologists

The Radiation Oncology Center at the University of Arkansas for Medical Sciences (UAMS) has received the highest national accreditation from the American Society for Radiation Oncology (ASTRO). The center, which is part of the UAMS Winthrop P. Rockefeller Cancer Institute, is the only radiation oncology center in the state to be granted full accreditation by…


January 13, 2022

First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well

Linda Haymes

Dave and Lori Puente of Elk Grove, California. Dave Puente is the first myeloma patient in Arkansas to receive new chimeric antigen receptor (CAR) T-cell immunotherapy treatment, which is only available at the UAMS Myeloma Center in the Winthrop P. Rockefeller Cancer Institute.

Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.


November 15, 2021

Pioneering Researcher Returns to UAMS Myeloma Center

Linda Haymes

“Dr. Shaughnessy’s return to UAMS expands and strengthens our research and subsequent treatment here at the Myeloma Center,” said Fenghuang “Frank” Zhan, director of research at the Myeloma Center.

John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…


November 10, 2021

UAMS Raises $15 Million Toward NCI Designation

Benjamin Waldrum

From left to right, Winthrop P. Rockefeller Cancer Institute Director Michael Birrer, M.D., Ph.D., UAMS Chancellor Cam Patterson, M.D., MBA, Chris and Kim Fowler, and James Suen, M.D.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it has raised more than $15 million towards NCI Designation, the halfway point toward its $30 million goal.


September 21, 2021

Be a Part of the Cure Telethon Raises $400,000

Marty Trieschmann

Event Chairs Natalie and Win Rockefeller and Emcee KATV’s Renee Shapiro welcome viewers to the telethon.

The 2nd annual Be a Part of the Cure Telethon to benefit the UAMS Winthrop P. Rockefeller Cancer Institute’s research and treatment programs raised nearly $400,000 despite a second year of pandemic challenges. “Cancer has affected us all, and the Winthrop P. Rockefeller Cancer Institute continues to see patients, provide treatment and take care of…


August 24, 2021

UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8

Marty Trieschmann

"Be A Part of The Cure" and text or call in your donation in support of our cancer research efforts.

Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…


August 10, 2021

Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center

Linda Haymes

Samer Al Hadidi, M.D.

LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…



Next page